Hormone therapy use and risk of ovarian cancer
JAMA
.
2009 Nov 25;302(20):2203; author reply 2204.
doi: 10.1001/jama.2009.1724.
Authors
Alastair H MacLennan
,
Rodney Baber
PMID:
19934418
DOI:
10.1001/jama.2009.1724
No abstract available
Publication types
Letter
Comment
MeSH terms
Bias
Estrogen Replacement Therapy / adverse effects*
Female
Humans
Ovarian Neoplasms / epidemiology*
Ovarian Neoplasms / etiology
Risk Assessment
Risk Factors